Alzheimer’s Association should reveal financial conflict of interest in urging FDA to approve Biogen drug, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest
MCI 911Biogen tried, and failed, to win FDA committee approval for its anti-amyloid Alzheimer's drug. The Alzheimer's Association supported the application but did not reveal significant monies received from the firm.